Financial reports
NT 20-F
Notice of late annual filing (foreign)
1 May 18
20-F
2016 FY
Annual report (foreign)
30 Mar 17
20-F
2015 FY
Annual report (foreign)
23 Mar 16
20-F
2014 FY
Annual report (foreign)
16 Mar 15
20-F
2013 FY
Annual report (foreign)
31 Mar 14
20-F/A
2012 FY
Annual report (foreign) (amended)
14 May 13
20-F
2012 FY
Annual report (foreign)
22 Mar 13
20-F/A
2011 FY
Annual report (foreign) (amended)
1 May 12
20-F
2011 FY
Annual report (foreign)
2 Apr 12
20-F/A
2010 FY
Annual report (foreign) (amended)
20 Jun 11
Current reports
6-K
Current report (foreign)
18 May 18
6-K
Current report (foreign)
27 Apr 18
6-K
Rosetta Genomics Announces Shareholder Approval of Merger with Genoptix
26 Apr 18
6-K
Current report (foreign)
19 Apr 18
6-K
Amendment No. 2 to Agreement and Plan of Merger
19 Apr 18
6-K
Rosetta Genomics Urges Shareholders to Vote FOR the Proposed Merger with Genoptix
17 Apr 18
6-K
If shareholders do not approve the merger, outstanding ordinary shares likely will cease to have any value
10 Apr 18
6-K
Current report (foreign)
10 Apr 18
6-K
Rosetta Genomics Urges Shareholders to Vote FOR the Proposed Merger with Genoptix
5 Apr 18
6-K
Current report (foreign)
13 Mar 18
Registration and prospectus
25-NSE
Exchange delisting
19 Jul 18
F-1
Registration statement (foreign)
16 Oct 17
424B4
Prospectus supplement with pricing info
7 Aug 17
POS EX
Additional exhibits for listing
7 Aug 17
F-1/A
Registration statement (foreign) (amended)
2 Aug 17
F-1/A
Registration statement (foreign) (amended)
28 Jul 17
F-1/A
Registration statement (foreign) (amended)
26 Jul 17
F-1/A
Registration statement (foreign) (amended)
17 May 17
F-1/A
Registration statement (foreign) (amended)
15 May 17
F-1
Registration statement (foreign)
8 May 17
Proxies
No filings
Other
EFFECT
Notice of effectiveness
27 Oct 17
CORRESP
Correspondence with SEC
25 Oct 17
UPLOAD
Letter from SEC
24 Oct 17
EFFECT
Notice of effectiveness
3 Aug 17
CORRESP
Correspondence with SEC
2 Aug 17
CORRESP
Correspondence with SEC
2 Aug 17
CORRESP
Correspondence with SEC
25 Jul 17
CORRESP
Correspondence with SEC
25 Jul 17
CORRESP
Correspondence with SEC
17 May 17
CORRESP
Correspondence with SEC
17 May 17
Ownership
4
Change in insider ownership
22 Apr 19
SC 13G/A
Rosetta Genomics Ltd.
4 Jan 19
SC 13G/A
Rosetta Genomics Ltd.
7 Jun 18
4
Change in insider ownership
27 Apr 18
4
Change in insider ownership
19 Mar 18
4
Change in insider ownership
16 Mar 18
3
Initial statement of insider ownership
14 Mar 18
4
Change in insider ownership
14 Mar 18
SC 13G
Rosetta Genomics Ltd.
12 Mar 18
SC 13G/A
Rosetta Genomics Ltd.
12 Feb 18